BioSpace News Archive

Harmony Biosciences announced today that the company has been certified by independent analysts as a Great Place to Work® for the third year in a row.

Kala Pharmaceuticals, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, announced that management will participate in the following virtual healthcare investor conferences in March.

Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today announced that the Company will host a conference call with Dr. Neal Shore, medical director of the Carolina Urologic Research Center who will provide a clinical perspective on Vicineum

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Watchmaker Genomics today announced a broad partnership to enable innovative research across a wide range of high throughput sequencing applications including oncology and tumor profiling,

ABIONYX Pharma (FR0012616852 - ABNX - PEA PME eligible), a new generation biotech company dedicated to innovative therapies for patients, today announces positive clinical results from CER-001 in the LCAT (lecithin-cholesterol acyltransferase) deficiency disease published in the Annals of Internal Medicine.

Cognito Therapeutics, a clinical-stage company leading the development of a new class of disease-modifying digital therapeutics to treat neurodegenerative disorders, announced today it will present for the first time, new clinical data for its digital therapeutic utilizing gamma frequency neuromodulation in Alzheimer’s Disease, at the 15th International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD), held virtually March 9-14, 2021.

Virpax Pharmaceuticals Inc. (NASDAQ:VRPX), a company specializing in developing pharmaceutical products for pain management, today announced that the United States Patent and Trademark Office issued US Patent No. 10842745 entitled, Composition of matter comprising liposome embedded in a polymerix matrix and methods of using same.

entrotech life sciences, inc., an organization focused on helping healthcare professionals save lives, is expanding its suite of PrevahexCHX Antimicrobial Dressings to include a transparent securement dressing for central venous access devices (CVAD), as well as a new-and-improved version of its peripheral IV (PIV) securement dressing.

Agenus (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines designed to activate immune response to cancers and infections, today announced it will release its fourth quarter and full year 2020 financial results before the market opens on Monday, March 15, 2021